Bellevue-based shipping startup Pandion has closed. Pandion founder and CEO Scott Ruffin announced the decision earlier this month on LinkedIn. The move comes after the company raised multiple ...
Merck & Co/MSD has agreed to buy Pandion for $1.85 billion, bolting on a pipeline of drugs for autoimmune and other immunological disorders headed by interleukin-2 (IL-2) based therapy PT-101.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback